Shares of Inventurus Knowledge Solutions Ltd., a stock backed by the family of late Rakesh Jhunjhunwala, fell as much as 10% on Monday, March 17, after the company’s shareholder lock-in period ended.As many as 42 lakh shares or 2% of the company’s outstanding equity became eligible to be traded after the three-month lock-in period of the company came to an end, according to data from Nuvama Alternative and Quantitative.
Before Monday’s fall, shares of IKS Health had declined 25% from their post-listing high but was still higher by 24% when compared to its issue price of ₹1,331 per share.
Based on the December quarter shareholding pattern, promoters of IKS Health had a 63.72% stake in the company.
The Nistha Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust and Aryaman Jhunjhunwala Discretionary Trust had a 16.37% stake each in the company at the end of the December quarter.Rekha Rakesh Jhunjhunwala, in her individual capacity, had a 0.23% stake at the end of the December quarter.
Before Monday’s fall, shares of IKS Health had declined 25% from their post-listing high but was still higher by 24% when compared to its issue price of ₹1,331 per share.
Based on the December quarter shareholding pattern, promoters of IKS Health had a 63.72% stake in the company.
The Nistha Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust and Aryaman Jhunjhunwala Discretionary Trust had a 16.37% stake each in the company at the end of the December quarter.Rekha Rakesh Jhunjhunwala, in her individual capacity, had a 0.23% stake at the end of the December quarter.
In an interaction with CNBC-TV18 last month, the management of IKS Health had mentioned that it expects the March quarter to be stronger than the December quarter and that the margins will be in the mid-30% levels starting financial year 2026.
The management also added that it continues to generate strong cash flow, which will help pare down existing debt as well.
Shares of Inventurus Knowledge Solutions Ltd. are trading 10% lower on Monday at ₹1,497. This after the stock fell to its lowest level since listing at ₹1,440.
